tradingkey.logo
๎™๊ฒ€์ƒ‰
์‹œ์žฅ
๊ด€์‹ฌ ๋ชฉ๋ก
๋‰ด์Šค
๋ถ„์„
๋„๊ตฌ
์ข…๋ชฉ ์Šคํฌ๋ฆฌ๋„ˆ
๎™ผ
๎˜
English
็นไฝ“ไธญๆ–‡
เน„เธ—เธข
Tiแบฟng viแป‡t
็ฎ€ไฝ“ไธญๆ–‡
Espaรฑol
Portuguรชs
Deutsch
ํ•œ๊ตญ์–ด
๎˜ณ
ๆ—ฅๆœฌ่ชž
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™
๎˜

Milestone Pharmaceuticals Inc

MIST
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
0.662USD
0.0000.00%
์ข…๊ฐ€ย 11-11 16:00๏ผˆET๏ผ‰
82.42M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

Milestone Pharmaceuticals Inc

0.662
0.0000.00%
๊ฐœ์š”
๋‰ด์Šค & ๋ถ„์„
๊ธˆ์œต
์ฃผ์‹ ์ ์ˆ˜
๊ธฐ์ˆ 
์˜ˆ์ƒ
์†Œ์œ ๊ถŒ
๋ฐฐ๋‹น๊ธˆ
ํ”„๋กœํ•„
ํ† ๋ก 
์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

๊ฐœ์š”

๋‰ด์Šค & ๋ถ„์„

๊ธˆ์œต

์ฃผ์‹ ์ ์ˆ˜

๊ธฐ์ˆ 

์˜ˆ์ƒ

์†Œ์œ ๊ถŒ

๋ฐฐ๋‹น๊ธˆ

ํ”„๋กœํ•„

ํ† ๋ก 

์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

MIST ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Milestone Pharmaceuticals Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋Š ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ํ•ต์‹ฌ ์žฌ๋ฌด ๋น„์œจ
์‹œ๊ฐ€์ด์•ก
82.42M
๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
0.00
P/E TTM
-1.06
์ฃผ๋‹น์ˆœ์ด์ต
-0.64
์ˆ˜์ต
1.55M
์ˆœ์ด์ต
-41.52M
ROE
-456.88%
ROA
-53.49%
Milestone Pharmaceuticals Inc ์‹ค์  ๋ฐœํ‘œ์ผ๎˜
์ตœ์‹  ์ถœ์‹œ
Nov 13, 2026
EPS / ์˜ˆ์ƒ
--/-0.22
์ˆ˜์ต / ์˜ˆ์ƒ
--/1.14M

์žฌ๋ฌด์ œํ‘œ ์š”์•ฝ

๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
์žฌ๋ฌด ์ง€ํ‘œ
EPS
-5.62%-0.21
48.48%-0.20
11.99%-0.16
13.36%-0.12
-38.03%-0.20
-88.10%-0.39
40.98%-0.19
59.37%-0.14
62.13%-0.14
40.82%-0.21
-2.63%-0.32
---0.35
---0.37
---0.35
---0.31
---1.07
----
----
----
----
์ˆ˜์ต
--559.00K
--238.00K
--1.55M
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
--0.00
--1.00M
--3.50M
--1.50M
-100.00%0.00
----
--0.00
--0.00
์ˆœ์ด์ต
-120.68%-28.61M
-25.55%-26.07M
-40.82%-17.41M
-26.31%-11.92M
-38.48%-12.97M
-100.51%-20.76M
9.17%-12.36M
37.41%-9.44M
41.64%-9.36M
30.74%-10.35M
-3.29%-13.61M
-3.61%-15.08M
3.63%-16.04M
-6.73%-14.95M
21.96%-13.18M
-2.33%-14.56M
-2262.08%-16.65M
-11.93%-14.01M
-94.83%-16.88M
-18.75%-14.22M
์ˆœ์ด์ต๋ฅ 
---5118.78%
---10952.10%
---1126.07%
----
----
----
----
----
----
----
----
----
----
---1495.00%
---376.49%
---3014.07%
----
----
----
----
์ด ์ด์ต๋ฅ 
--94.28%
--94.12%
--100.00%
----
----
----
----
----
----
----
----
----
----
--100.00%
--100.00%
--100.00%
----
----
----
----
๋ถ€์ฑ„๋น„์œจ
-33.37%77.62%
-19.80%70.36%
-28.73%50.36%
1.03%64.05%
101.72%116.49%
66.29%87.72%
6.81%70.67%
12.91%63.40%
16.55%57.75%
23.83%52.75%
--66.16%
--56.15%
--49.55%
--42.60%
----
----
----
----
----
----
์†์ต๊ณ„์‚ฐ์„œ๎˜
์ˆ˜์ต
--559.00K
--238.00K
--1.55M
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
--0.00
--1.00M
--3.50M
--1.50M
-100.00%0.00
----
--0.00
--0.00
์˜์—… ์ด์ต
-104.53%-25.63M
-15.30%-23.66M
-39.02%-17.26M
-22.24%-11.83M
-28.83%-12.53M
-94.64%-20.52M
10.05%-12.41M
37.00%-9.68M
40.82%-9.73M
31.98%-10.54M
-0.30%-13.80M
-2.20%-15.36M
2.20%-16.44M
-10.36%-15.50M
18.67%-13.76M
-5.30%-15.03M
-2460.39%-16.81M
-11.54%-14.05M
-93.08%-16.92M
-18.11%-14.27M
์ˆœ์ด์ต
-120.68%-28.61M
-25.55%-26.07M
-40.82%-17.41M
-26.31%-11.92M
-38.48%-12.97M
-100.51%-20.76M
9.17%-12.36M
37.41%-9.44M
41.64%-9.36M
30.74%-10.35M
-3.29%-13.61M
-3.61%-15.08M
3.63%-16.04M
-6.73%-14.95M
21.96%-13.18M
-2.33%-14.56M
-2262.08%-16.65M
-11.93%-14.01M
-94.83%-16.88M
-18.75%-14.22M
์žฌ๋ฌด์ƒํƒœํ‘œ๎˜
์œ ๋™์ž์‚ฐ
290.59%180.33M
217.90%192.25M
51.40%111.92M
7.01%86.67M
-47.15%46.17M
-35.64%60.48M
1.22%73.93M
-4.49%80.99M
-7.62%87.36M
-13.40%93.97M
1.71%73.03M
2.26%84.80M
4.49%94.57M
3.37%108.51M
-39.62%71.80M
-37.54%82.92M
-37.32%90.50M
-23.52%104.97M
-20.02%118.92M
23.59%132.76M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
138.97%22.18M
61.57%20.94M
72.03%13.98M
100.15%10.52M
103.26%9.28M
213.87%12.96M
12.46%8.13M
-35.20%5.26M
-32.93%4.57M
-48.14%4.13M
17.71%7.23M
24.41%8.11M
59.99%6.81M
72.73%7.96M
-9.39%6.14M
11.54%6.52M
-20.12%4.26M
-20.74%4.61M
10.00%6.78M
-0.58%5.85M
์ด ์ž์‚ฐ
283.04%181.63M
213.05%193.73M
50.41%113.56M
6.10%87.75M
-46.86%47.42M
-35.54%61.88M
0.36%75.50M
-5.06%82.71M
-8.03%89.23M
-13.57%96.00M
1.00%75.23M
1.57%87.12M
6.27%97.02M
4.99%111.08M
-37.85%74.48M
-35.89%85.77M
-37.25%91.30M
-23.58%105.80M
-20.09%119.85M
22.96%133.78M
๋ถ€์ฑ„ ์ด๊ณ„
150.77%163.41M
131.86%157.69M
15.14%71.79M
14.58%67.25M
13.81%65.16M
21.27%68.01M
6.67%62.35M
0.14%58.69M
1.14%57.25M
-1.86%56.08M
618.56%58.45M
580.43%58.61M
1120.06%56.61M
1033.15%57.15M
12.22%8.13M
35.46%8.61M
-21.37%4.64M
-21.83%5.04M
5.75%7.25M
-3.64%6.36M
์ž๋ณธ ์ด๊ณ„
202.67%18.22M
688.75%36.05M
217.71%41.77M
-14.62%20.50M
-155.49%-17.75M
-115.34%-6.12M
-21.61%13.15M
-15.76%24.01M
-20.86%31.98M
-25.98%39.92M
-74.72%16.77M
-63.06%28.50M
-53.37%40.41M
-46.47%53.94M
-41.08%66.35M
-39.45%77.16M
-37.92%86.66M
-23.67%100.76M
-21.32%112.60M
24.68%127.42M
ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๎˜
์ˆœ์˜์—…์ด์ต
-80.76%-22.71M
-15.06%-16.05M
-86.69%-12.78M
-38.90%-9.75M
-107.60%-12.57M
-56.17%-13.95M
30.14%-6.84M
42.29%-7.02M
42.70%-6.05M
35.75%-8.93M
23.84%-9.80M
-5.07%-12.16M
25.00%-10.56M
0.32%-13.90M
-3.92%-12.86M
-23.22%-11.57M
-1487.68%-14.09M
-11.86%-13.95M
-41.34%-12.38M
-28.06%-9.39M
์ˆœํˆฌ์ž
1026.23%111.99M
-338.31%-80.03M
-86.02%2.70M
-639.79%-34.98M
4.87%9.94M
224.32%33.58M
41.37%19.33M
159.69%6.48M
133.83%9.48M
-190.14%-27.01M
180.38%13.68M
36.32%-10.86M
-86.14%-28.03M
474.60%29.97M
-213.43%-17.02M
-174.13%-17.05M
-175.29%-15.06M
-166.67%-8.00M
207.14%15.00M
195.83%23.00M
์ˆœ์žฌ๋ฌดํ™œ๋™
25269.44%9.13M
67295.71%94.35M
151704.17%36.43M
66005.41%48.92M
112.08%36.00K
-99.57%140.00K
2300.00%24.00K
-75.74%74.00K
89.23%-298.00K
-35.69%32.32M
-99.56%1.00K
-88.59%305.00K
-2076.43%-2.77M
102457.14%50.25M
146.74%227.00K
11033.33%2.67M
-97.15%140.00K
157.89%49.00K
-99.81%92.00K
-99.90%24.00K

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Milestone Pharmaceuticals Inc์˜ ์ด์ˆ˜์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Milestone Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์€ 1.55M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 1.55M์ž…๋‹ˆ๋‹ค.

Milestone Pharmaceuticals Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Milestone Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 111.92M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 51.40์ž…๋‹ˆ๋‹ค.

Milestone Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Milestone Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Milestone Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์€ 113.56M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 50.41์ž…๋‹ˆ๋‹ค.

Milestone Pharmaceuticals Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Milestone Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Milestone Pharmaceuticals Inc์˜ ์ด๋ถ€์ฑ„๋Š” 71.79M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 15.14์ž…๋‹ˆ๋‹ค.

Milestone Pharmaceuticals Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Milestone Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Milestone Pharmaceuticals Inc์˜ ์ด์ž๋ณธ์€ 41.77M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 217.71์ž…๋‹ˆ๋‹ค.

Milestone Pharmaceuticals Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Milestone Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Milestone Pharmaceuticals Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -62.48M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -47.51์ž…๋‹ˆ๋‹ค.

Milestone Pharmaceuticals Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Milestone Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Milestone Pharmaceuticals Inc์˜ ์ˆœํˆฌ์ž๋Š” 11.25M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 35.77์ž…๋‹ˆ๋‹ค.

Milestone Pharmaceuticals Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Milestone Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Milestone Pharmaceuticals Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 85.53M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 166.28์ž…๋‹ˆ๋‹ค.

Milestone Pharmaceuticals Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Milestone Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -0.75์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -12.64์ž…๋‹ˆ๋‹ค.

Milestone Pharmaceuticals Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Milestone Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -63.06M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -51.88์ž…๋‹ˆ๋‹ค.

Milestone Pharmaceuticals Inc์˜ ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Milestone Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ 50.36์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -28.73์ž…๋‹ˆ๋‹ค.

Milestone Pharmaceuticals Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Milestone Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -229.65์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 17.26์ž…๋‹ˆ๋‹ค.

Milestone Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Milestone Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -66.71์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -21.08์ž…๋‹ˆ๋‹ค.

Milestone Pharmaceuticals Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Milestone Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -62.48M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -47.51์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ 
์ด์šฉ ์•ฝ๊ด€
๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ
์ฟ ํ‚ค ์ •์ฑ